Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NK1 antagonists described by Merck & Co.

Nov. 8, 1996

NPS Pharm. selects NMDA antagonist for further testing

Nov. 1, 1996

Pfizer describes a new series of CRF antagonists

Nov. 1, 1996

Japanese researchers disclose glutamate antagonists

Nov. 1, 1996

Alzheimer's disease linked to immunoinflammatory response

Nov. 1, 1996

Eisai files for approval of Aricept

Nov. 1, 1996

Meiji Seika discloses compounds that enhance axonal regeneration

Nov. 1, 1996

Merck NK1 antagonist shows antiemetic activity in ferrets

Nov. 1, 1996

N-type calcium channel blockers from Sankyo

Nov. 1, 1996

Pfizer 5-HT reuptake inhibitor approved in U.S. for new indication

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...